Top Global Growth Stocks

Top Global Growth Stocks

UPDATED Aug 11, 2022

What are the best Global Growth Stocks?

According to our Simply Wall St analysis these are the best Global growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

Our criteria to find Top Growth Companies

Growth

  • Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.

What do we look for?

  • Is the company forecast to have high earnings growth.

Healthy Balance Sheet

  • A healthy balance sheet is essential to drive growth opportunities and sustain the business.
  • Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.

What do we look for?

  • Does the company have a manageable level of debt.
  • Is the company able to cover its interest repayments.

707 companies meet this criteria in the Global market

M Vest Water AS, an environmental technology company, provides solutions for water and wastewater treatment.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: MVW is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 95.9% below our estimate of its fair value

  • Earnings are forecast to grow 84.49% per year

Risks

  • Makes less than USD$1m in revenue (NOK674K)

  • Does not have a meaningful market cap (NOK310M)

  • Volatile share price over the past 3 months

View all Risks and Rewards

Digital360 S.p.A. operates multi-channel B2B platform in Italy.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: DIG's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 70.9% below our estimate of its fair value

  • Earnings are forecast to grow 39.95% per year

  • Earnings grew by 68.5% over the past year

Risks

  • Does not have a meaningful market cap (€94M)

  • Shareholders have been diluted in the past year

View all Risks and Rewards

Eneraqua Technologies plc provides turnkey solutions for water efficiency and decarbonization through district heating and ground source heat pump systems for commercial clients, and social housing and residential sectors.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: ETP's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 31.9% below our estimate of its fair value

  • Earnings are forecast to grow 31.96% per year

  • Earnings grew by 345.6% over the past year

Risks

  • High level of non-cash earnings

View all Risks and Rewards

Migros Ticaret A.S., together with its subsidiaries, engages in the retail sale of food and beverages, and consumer and durable goods.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: MGROS's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 57.7% below our estimate of its fair value

  • Earnings are forecast to grow 46.95% per year

  • Earnings grew by 794.7% over the past year

Risks

No risks detected for MGROS from our risks checks.

View all Risks and Rewards

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: CALTX is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 98.3% below our estimate of its fair value

  • Earnings are forecast to grow 60.2% per year

Risks

  • Shareholders have been diluted in the past year

View all Risks and Rewards

Coca-Cola Içecek Anonim Sirketi, together with its subsidiaries, engages in bottling and distributing of alcohol-free beverages primarily in Turkey, Pakistan, Central Asia, and the Middle East.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: CCOLA's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 20.9% below our estimate of its fair value

  • Earnings are forecast to grow 36.93% per year

  • Earnings grew by 60.6% over the past year

Risks

No risks detected for CCOLA from our risks checks.

View all Risks and Rewards

LPKF Laser & Electronics AG, together with its subsidiaries, designs and manufactures laser-based solutions for the technology industry in Germany, rest of Europe, the United States, rest of North America, China, Malaysia, Vietnam, rest of Asia, and internationally.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: LPK's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 69.9% below our estimate of its fair value

  • Earnings are forecast to grow 73.32% per year

  • Became profitable this year

Risks

No risks detected for LPK from our risks checks.

View all Risks and Rewards

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: ACAD is expected to become profitable in the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 87.4% below our estimate of its fair value

  • Earnings are forecast to grow 77.59% per year

  • Earnings have grown 6.4% per year over the past 5 years

Risks

  • Volatile share price over the past 3 months

View all Risks and Rewards
Page 1 of 89